JAK Inhibitors: What Is New?
Virginia Reddy, Stanley Cohen
Topics & Concepts
TofacitinibMedicineJanus kinaseRheumatoid arthritisSafety profileJanus kinase inhibitorClinical trialInternal medicineRheumatologyPharmacologyOncologyAdverse effectReceptorRheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and InteractionsChronic Lymphocytic Leukemia Research